Document and Entity Information
Document Type
Document Quarterly Report
Document Period End Date
Document Transition Report
Entity File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Shell Company
Entity Common Stock, Shares Outstanding
Entity Central Index Key
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Amendment Flag
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
Statement [Table]
Statement [Table]
Statement [Line Items]
Statement
Assets [Abstract]
ASSETS
Assets, Current [Abstract]
Current Assets:
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Short-term Investments
Short-term deposit (Note 4)
Nontrade Receivables, Current
Other accounts receivable
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Assets, Current
Total current assets
Assets, Noncurrent [Abstract]
Long-Term Assets:
Prepaid Expense and Other Assets, Noncurrent
Prepaid expenses and other long-term assets
Operating Lease, Right-of-Use Asset
Operating lease right of use asset (Note 6)
Operating lease right of use asset
Property, Plant and Equipment, Net
Property and Equipment, Net
Other Assets, Noncurrent
Total Long-Term Assets
Assets
Total assets
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Liabilities, Current [Abstract]
Current Liabilities:
Accounts Payable, Current
Accounts payables
Accrued Liabilities, Current
Accrued expenses
Operating Lease, Liability, Current
Operating lease liability (Note 5)
The amount represents the other accounts payable current.
Other Accounts Payable Current
Other accounts payables
Liabilities, Current
Total current liabilities
Liabilities, Noncurrent [Abstract]
Long-Term Liabilities:
Operating Lease, Liability, Noncurrent
Operating lease liability (Note 5)
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent
Warrants liability (Note 6)
Liabilities, Noncurrent
Total long-term liabilities
Liabilities
Total liabilities
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' Equity:
Common Stock, Value, Issued
Stock capital: (Note 7) Common Stock of $0.00005 par value - Authorized: 100,000,000 shares September 30, 2023 and December 31, 2022 respectively; Issued and outstanding: 45,314,961 and 36,694,078 shares at September 30, 2023 and December 31, 2022 respectively.
Additional Paid in Capital, Common Stock
Additional paid-in-capital
Treasury Stock, Common, Value
Treasury stocks
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Stockholders' Equity Attributable to Parent
Balance
Balance
Total stockholders' equity (deficit)
Liabilities and Equity
Total liabilities and stockholders' equity (deficit)
Common Stock, Par or Stated Value Per Share
Common Stock, par value (in dollars per share)
Common Stock, Shares Authorized
Common Stock, shares authorized
Common Stock, Shares, Issued
Common Stock, shares issued
Common Stock, Shares, Outstanding
Common Stock, shares outstanding
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)
Operating Expenses [Abstract]
Operating expenses:
Research and Development Expense
Research and development, net
General and Administrative Expense
General and administrative
Operating Income (Loss)
Operating loss
Represents the amount of financial expenses (income), net during the period.
Financial Expenses Income Net
Financial income (expenses), net
Amount of expense (income) related to adjustment to fair value of warrant liability and stock issuance costs.
Fair Value Adjustments Of Warrants And Stock Issuance Costs
Gain on change in fair value of Warrants liability (Note 6)
Net Income (Loss) Attributable to Parent
Net loss
Net loss
Earnings Per Share, Basic
Basic net loss per share from continuing operations
Earnings Per Share, Diluted
Diluted net loss per share from continuing operations
Weighted Average Number of Shares Outstanding, Basic
Weighted average number of shares outstanding used in computing basic net loss per share
Weighted Average Number of Shares Outstanding, Diluted
Weighted average number of shares outstanding used in computing diluted net loss per share
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIT (UNAUDITED)
Equity Components [Axis]
Equity Component [Domain]
Common Stock [Member]
Common Stock
Common stock
Additional Paid-in Capital [Member]
Additional paid-in capital
Treasury Stocks [Member]
Treasury stocks
Accumulated Deficit [Member]
Accumulated deficit
Shares, Outstanding
Balance (in shares)
Balance (in shares)
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Stock-based compensation related to stock and options granted to directors and employees
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures
Stock-based compensation related to stock and options granted to directors and employees (in shares)
Represents the information pertaining to issuance under at the market.
Issuance Of Shares At The Market
Issuance of shares in at-the-market (ATM) offering (Note 7)
Represents the information pertaining to issuance under at the market.
Issuance Of Share Value
Issuance of shares in at-the-market (ATM) offering (Note 7) (in shares)
Number of shares value for private placement.
Issuance of shares for private placement value
Issuance of shares for private placement (Note 7)
Number of shares issued for private placement.
Issuance of shares for private placement
Issuance of shares for private placement (Note 7) (shares)
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash flows used in operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Depreciation
Stock or Unit Option Plan Expense
Stock-based compensation related to options granted to employees and directors
Increase (Decrease) in Operating Lease Liability
Change in operating lease liability
It represents the increase (decrease) during the reporting period in accounts receivable and prepaid expenses.
Increase Decrease In Accounts Receivable and Prepaid Expenses
Decrease in other accounts receivable and prepaid expenses
Increase (Decrease) in Accounts Payable, Trade
Increase (decrease) in trade payables
Fair Value Adjustment of Warrants
Change in fair value of Warrants liability
Gain on change in fair value of warrants (Note 6)
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Increase (decrease) in other accounts payable and accrued expenses
Net Cash Provided by (Used in) Operating Activities
Total net cash used in operating activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Payments for (Proceeds from) Investments
Changes in short-term deposit
Net Cash Provided by (Used in) Investing Activities
Total net cash provided by (used in) investing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities:
Amount of cash inflow from at the market.
Proceeds From At The Market
Proceeds from issuance of shares in at-the-market (ATM) offering (Note 7)
Proceeds from Issuance of Private Placement
Proceeds from Issuance of shares for private placement (Note 7)
Net Cash Provided by (Used in) Financing Activities
Total net cash provided by financing activities
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Increase (decrease) in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash and cash equivalents at end of the period
Cash and cash equivalents at the beginning of the period
GENERAL
Business Description and Basis of Presentation [Text Block]
GENERAL
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Significant Accounting Policies [Text Block]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
RESEARCH AND LICENSE AGREEMENT
The entire disclosure on research and license agreement entered by the entity.
Research and License Agreement [Text Block]
RESEARCH AND LICENSE AGREEMENT
SHORT TERM DEPOSITS
The entire disclosure of the components short-term deposits.
Short Term Deposits Disclosure [Text Block]
SHORT TERM DEPOSITS
LEASES
Lessee, Operating Leases [Text Block]
LEASES
WARRANTS LIABILITY
The entire disclosure of warrants liability.
Warrants Liability Disclosure [Text Block]
WARRANTS LIABILITY
STOCK CAPITAL
Stockholders' Equity Note Disclosure [Text Block]
STOCK CAPITAL
FAIR VALUE MEASUREMENT
Fair Value Disclosures [Text Block]
FAIR VALUE MEASUREMENT
SUBSEQUENT EVENTS
Subsequent Events [Text Block]
SUBSEQUENT EVENTS
Disclosure of accounting policy pertaining to unaudited interim financial statements.
Unaudited Interim Financial Statements Policy [Policy Text Block]
Unaudited Interim Financial Statements
Significant Accounting Policies [Text Block]
Significant Accounting Policies
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Standards
Use of Estimates, Policy [Policy Text Block]
Use of estimates
Lease, Cost [Table Text Block]
Schedule of supplemental cash flow information related to operating leases
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Schedule of future lease payments under operating leases
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of fair value assumptions used for the stock options granted
Share-based Compensation, Stock Options, Activity [Table Text Block]
Summary of the Company's option activity
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
Schedule of compensation expense for restricted stock is based on fair market value at the grant date
Tabular disclosure includes the number and weighted-average issue prices for warrants issued to services providers that were outstanding at the beginning and end of the year, and issued during the year.
Schedule Stock Awards Activity Related To Service Providers [Table Text Block]
Schedule of total stock-based compensation expense
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Schedule of assumptions used to determine fair value of July 2023 warrants
Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is covered by a valid claim or is covered by orphan drug status.
Percentage of Royalty Payment if Licensed Product Covered by Valid Claim or Orphan Drug Status
Percentage of royalty payment if licensed product covered by valid claim or orphan drug status
Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is not covered by a valid claim or is not covered by orphan drug status.
Percentage of Royalty Payment If Licensed Product Not Covered by Valid Claim or Orphan Drug Status
Percentage of royalty payment if licensed product not covered by valid claim or orphan drug status
This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Validity of Royalty Payment Not Covered by Valid Claim or Orphan Drug Status
Validity of royalty payment not covered by valid claim or orphan drug status
Tabular disclosure of short term deposits.
Schedule of Short Term Deposits [Table]
Statistical Measurement [Axis]
Statistical Measurement [Domain]
Minimum [Member]
Minimum
Maximum [Member]
Maximum
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Short Term Deposits [Line Items]
SHORT TERM DEPOSITS
Investment Interest Rate
Annual interest rate on bank deposits
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Line Items]
LEASES
Operating Lease, Liability
Operating lease liability
Total lease liability balance
Operating Lease, Weighted Average Remaining Lease Term
Operating lease, weighted average remaining lease term
Operating Lease, Weighted Average Discount Rate, Percent
Operating lease, weighted average discount rate percent
Operating Lease, Payments
Cash payments for operating leases
Lessee, Operating Lease, Liability, to be Paid, Year One
2023
Lessee, Operating Lease, Liability, to be Paid, Year Two
2024
Lessee, Operating Lease, Liability, to be Paid, Year Three
2025
Lessee, Operating Lease, Liability, to be Paid, Year Four
2026
Lessee, Operating Lease, Liability, to be Paid
Total future lease payments
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less imputed interest
Class of Warrant or Right [Table]
Warrant [Member]
Private placement warrants
Class of Warrant or Right [Axis]
Class of Warrant or Right [Domain]
Represents the information pertaining to July 2023 warrants.
July 2023 Warrants [Member]
July 2023 warrants
Class of Warrant or Right [Line Items]
WARRANTS LIABILITY
Stock Issued During Period, Shares, New Issues
Aggregate shares sold
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants to purchase shares of common stock
The cash inflow associated with the amount received from issuance of common stock and from holders exercising their stock warrants.
Proceeds from Issuance of Common Stock and Warrants Exercises
Gross proceeds
The carrying amount of issuance costs related to warrants liability and equity.
Warrants Liability and Equity, Issuance Costs
Total issuance costs
The carrying amount of issuance costs related to warrants liability.
Warrant Liability, Issuance Costs
Total issuance costs allocated to warrants liability
The carrying amount of issuance costs related to equity.
Equity, Issuance Costs
Total issuance costs allocated to equity
Liabilities, Fair Value Disclosure
Fair value of warrants
Warrants and Rights Outstanding
Warrants outstanding
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Sale of Stock [Axis]
Sale of Stock [Domain]
This member represents at market offering.
At Market Offering [Member]
At Market Offering
Option Indexed to Issuer's Equity, Type [Axis]
Option Indexed to Issuer's Equity, Type [Domain]
This member stands for Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014.
Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 [Member]
Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014
Award Type [Axis]
Equity Award [Domain]
Share-Based Payment Arrangement, Option [Member]
Employee Stock Option
Restricted Stock [Member]
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
STOCK CAPITAL
Stock Issued During Period, Value, New Issues
Aggregate offering amount
Proceeds from Issuance of Common Stock
Gross proceeds
Stock Issued During Period, Shares, Issued for Services
Issuance of common stock
Common Stock, Capital Shares Reserved for Future Issuance
Future issuance of common stock
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Unrecognized compensation cost
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted average period
Share-based Compensation
Compensation expense (income)
Total stock-based compensation expense
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Represents the information pertaining to securities purchase agreement.
Securities Purchase Agreement [Member]
Securities purchase agreement
Represents the information pertaining to public offering.
Public Offering [Member]
Public offering
Shares Issued, Price Per Share
Purchase price per share
Proceeds from Issuance or Sale of Equity
Gross proceeds
Warrants and Rights Outstanding, Term
Warrants term
Class of Warrant or Right, Exercise price
Class of warrant exercise price
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period
Option life (years)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Risk-free interest, Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Risk-free interest, Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Dividend yield
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Expected volatility, Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Expected volatility, Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Expected life of up to (years)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Amount of options, Outstanding at end of period
Amount of options, Outstanding at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Amount of options, Granted
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Amount of options, Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Amount of options, Exercisable at end of period | shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted average exercise price, Outstanding at end of period (in dollars per share)
Weighted average exercise price, Outstanding at beginning of period (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted average exercise price, Granted (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted Average exercise Price, Forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Weighted average exercise price, Exercisable at end of period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of Shares of Restricted Stock, Nonvested at end of period
Number of Shares of Restricted Stock, Nonvested at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Nonvested at end of period
Weighted Average Grant Date Fair Value, Nonvested at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Weighted Average Remaining Contractual Term (Years), Nonvested
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Income Statement Location [Axis]
Income Statement Location [Domain]
Research and Development Expense [Member]
Research and development
General and Administrative Expense [Member]
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
STOCK CAPITAL
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value, Inputs, Level 3 [Member]
Level 3
Measurement Input Type [Axis]
Measurement Input Type [Domain]
Measurement Input, Maturity [Member]
Time to expiration
Measurement Input, Share Price [Member]
Common stock price
Measurement Input, Risk Free Interest Rate [Member]
Risk-free interest rate
Measurement Input, Price Volatility [Member]
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assumptions used to determine fair value of warrants
Warrants and Rights Outstanding, Measurement Input
Warrants liabilities, inputs
Subsequent Event [Table]
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Subsequent Event [Member]
Subsequent Event
Subsequent Event
SUBSEQUENT EVENTS
The percentage of targeted reduction in headcount.
Percentage of Targeted Reduction in Headcount
Percentage of targeted reduction in headcount